Regulatory Considerations for Generic or Biosimilar Low Molecular Weight Heparins

Publisher： Bentham Science Publishers

E-ISSN： 1875-6220|9|2|137-142

ISSN： 1570-1638

Source： Current Drug Discovery Technologies, Vol.9, Iss.2, 2012-06, pp. : 137-142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low molecular weight heparins

By Aguilar O.M.   Kleiman N.S.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 6, 2000-09 ,pp. : 1091-1103

Informa Healthcare

Access to resources Recommend Favorite

Pulmonary Delivery of Low Molecular Weight Heparins

By Yang Tianzhi   Mustafa Fatima   Bai Shuhua   Ahsan Fakhrul  

Pharmaceutical Research, Vol. 21, Iss. 11, 2004-11 ,pp. : 2009-2016

Springer Publishing Company

Access to resources Recommend Favorite

Formulary Management of Low Molecular Weight Heparins

By Wade W.E.   Martin B.C.   Kotzan J.A.   Spruill W.J.   Chisoholm M.A.   Perri M.  

PharmacoEconomics, Vol. 17, Iss. 1, 2000-01 ,pp. : 1-12

Adis International

Access to resources Recommend Favorite

Synthesis and Anticoagulant Activity of Low-Molecular-Weight Heparins

By Stolbushkina P. P.   Bannikova G. E.   Drozd N. N.   Makarov V. A.   Varlamov V. P.   Vikhoreva G. A.  

Pharmaceutical Chemistry Journal, Vol. 38, Iss. 2, 2004-02 ,pp. : 82-85

Springer Publishing Company

Access to resources Recommend Favorite

Low molecular weight heparins: Lumbar epidural haematomas: case report

By  

Reactions Weekly, Vol. 1, Iss. 1155, 2007-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite